OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Release Date
2025
(6)
2023
(6)
2022
(4)
2021
(4)
2024
(3)
2026
(2)
2016
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Virtual reality and augmented reality in ophthalmology: A recent update.
Not available
S-EPMC12515333
|
biostudies-literature
Cite
Applications of mesenchymal stem cells in ocular surface diseases: sources and routes of delivery.
Not available
S-EPMC10313829
|
biostudies-literature
Cite
Analysis of
IL-33
gene polymorphism (rs11792633 C/T) and risk of schizophrenia.
Not available
S-EPMC5019332
|
biostudies-literature
Cite
Intrastromal versus subconjunctival injection of mesenchymal stem/stromal cells for promoting corneal repair.
Not available
S-EPMC10841412
|
biostudies-literature
Cite
One-step nanoscale expansion microscopy reveals individual protein shapes.
Not available
S-EPMC7616833
|
biostudies-literature
Cite
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327
|
biostudies-literature
Cite
Summary of taxonomy changes ratified by the International Committee on Taxonomy of Viruses (ICTV) from the Bacterial Viruses Subcommittee, 2025.
Not available
S-EPMC12451628
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets